Centessa Pharmaceuticals Plc Stock Market Value
| CNTA Stock | USD 16.96 0.37 2.23% |
| Symbol | Centessa |
Centessa Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Centessa Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Centessa Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Centessa Pharmaceuticals.
| 09/03/2024 |
| 01/31/2025 |
If you would invest 0.00 in Centessa Pharmaceuticals on September 3, 2024 and sell it all today you would earn a total of 0.00 from holding Centessa Pharmaceuticals PLC or generate 0.0% return on investment in Centessa Pharmaceuticals over 150 days. Centessa Pharmaceuticals is related to or competes with Century Therapeutics, Edgewise Therapeutics, C4 Therapeutics, Mineralys Therapeutics,, Cullinan Oncology, NewAmsterdam Pharma, and Sutro Biopharma. Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to pa... More
Centessa Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Centessa Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Centessa Pharmaceuticals PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.82 | |||
| Information Ratio | 0.0375 | |||
| Maximum Drawdown | 15.71 | |||
| Value At Risk | (6.19) | |||
| Potential Upside | 6.35 |
Centessa Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Centessa Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Centessa Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Centessa Pharmaceuticals historical prices to predict the future Centessa Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0625 | |||
| Jensen Alpha | 0.1939 | |||
| Total Risk Alpha | (0.16) | |||
| Sortino Ratio | 0.0349 | |||
| Treynor Ratio | 0.6852 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Centessa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Centessa Pharmaceuticals Backtested Returns
At this point, Centessa Pharmaceuticals is not too volatile. Centessa Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0481, which signifies that the company had a 0.0481 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Centessa Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please confirm Centessa Pharmaceuticals' Risk Adjusted Performance of 0.0625, mean deviation of 2.71, and Downside Deviation of 3.82 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. Centessa Pharmaceuticals has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.33, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Centessa Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Centessa Pharmaceuticals is expected to be smaller as well. Centessa Pharmaceuticals right now shows a risk of 3.69%. Please confirm Centessa Pharmaceuticals total risk alpha, downside variance, daily balance of power, as well as the relationship between the maximum drawdown and skewness , to decide if Centessa Pharmaceuticals will be following its price patterns.
Auto-correlation | 0.18 |
Very weak predictability
Centessa Pharmaceuticals PLC has very weak predictability. Overlapping area represents the amount of predictability between Centessa Pharmaceuticals time series from 3rd of September 2024 to 17th of November 2024 and 17th of November 2024 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Centessa Pharmaceuticals price movement. The serial correlation of 0.18 indicates that over 18.0% of current Centessa Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.64 |
Centessa Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Centessa Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Centessa Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Centessa Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Centessa Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Centessa Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Centessa Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Centessa Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Centessa Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Centessa Pharmaceuticals Lagged Returns
When evaluating Centessa Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Centessa Pharmaceuticals stock have on its future price. Centessa Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Centessa Pharmaceuticals autocorrelation shows the relationship between Centessa Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Centessa Pharmaceuticals PLC.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Centessa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Centessa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Centessa Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Centessa Pharmaceuticals Plc Stock:Check out Centessa Pharmaceuticals Correlation, Centessa Pharmaceuticals Volatility and Centessa Pharmaceuticals Alpha and Beta module to complement your research on Centessa Pharmaceuticals. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Centessa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.